Current treatment of COPD

2018-01-26

Jadwiga Wedzicha

This lecture was recorded at the 3rd McMaster International Review Course in Internal Medicine in Kraków, Poland. To learn more, please visit www.mircim.eu.

See also

Nephrotic syndrome in adults: current management A lecture by Dr Jürgen Floege, from RWTH Aachen University, Germany, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Biologics in asthma–COPD overlap syndrome What is your opinion on the use of biologics in patients with asthma–chronic obstructive pulmonary disease overlap syndrome?
Use of full-face masks and helmets Full-face masks or helmets are not used universally in everyday practice. What is your experience with using such devices? Do you use them often in your practice? Which patients would benefit most from this type of intervention?
Asthma–COPD overlap syndrome A lecture by Prof. Paul O’Byrne, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.
Treatment of CAP and resistant pathogens There is a tendency to keep the duration of antibiotic treatment for community-acquired pneumonia as short as possible. Treatment of 5 days is safe and effective but is it associated with an increased risk of selection of resistant pathogens?

Current treatment of COPD

Social Media